0.9043
-0.0751
(-7.67%)
At close: 4:00:02 PM EDT
0.9483
+0.04
+(4.87%)
After hours: 4:06:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-229,905
-229,905
-184,162
-20,329
298,551
Investing Cash Flow
107,131
107,131
101,918
-159,014
-49,663
Financing Cash Flow
81,540
81,540
2,550
4,514
30,295
End Cash Position
34,867
34,867
76,101
155,795
330,624
Capital Expenditure
-1,255
-1,255
-2,381
-4,117
-3,247
Issuance of Capital Stock
71,108
71,108
--
--
--
Issuance of Debt
9,389
9,389
--
--
--
Free Cash Flow
-231,160
-231,160
-186,543
-24,446
295,304
12/31/2021 - 2/7/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DNLI Denali Therapeutics Inc.
12.50
-2.80%
VYGR Voyager Therapeutics, Inc.
2.9900
-3.86%
STOK Stoke Therapeutics, Inc.
6.52
+1.40%
PASG Passage Bio, Inc.
0.3619
-11.52%
LXEO Lexeo Therapeutics, Inc.
2.1700
-8.05%
CTMX CytomX Therapeutics, Inc.
0.4946
-1.14%
BCYC Bicycle Therapeutics plc
6.53
-5.09%
KYMR Kymera Therapeutics, Inc.
22.40
-6.47%
XNCR Xencor, Inc.
7.92
-10.10%
SRRK Scholar Rock Holding Corporation
26.31
-2.77%